Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H B Carter

Showing results (71-80 of 93) with videos related to

Pageof 10
Sort By:
The Journal of Urology|July 1, 1993
The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancerA W Partin, J Yoo, H B Carter, et al.
Radiology|February 1, 1991
Nonpalpable prostate cancer: detection with MR imagingH B Carter, R F Brem, C M Tempany, et al.
Urology|April 1, 1995
Prostate-specific antigen variability in men without prostate cancer: effect of sampling interval on prostate-specific antigen velocityH B Carter, J D Pearson, Z Waclawiw, et al.
Urology|February 1, 1997
Prostate-specific antigen in men born with bladder exstrophyR I Silver, A W Partin, J I Epstein, et al.
The Journal of Urology|July 1, 1992
Correlation of prostate cancer nuclear deoxyribonucleic acid, size, shape and Gleason grade with pathological stage at radical prostatectomyJ I Epstein, G Pizov, G D Steinberg, et al.
Urology|December 1, 1996
Longitudinal analysis of serial measurements of free and total PSA among men with and without prostatic cancerJ D Pearson, A A Luderer, E J Metter, et al.
The Prostate|July 1, 1995
Longitudinal evaluation of serum androgen levels in men with and without prostate cancerH B Carter, J D Pearson, E J Metter, et al.
The Journal of Urology|November 17, 1998
Nonpalpable stage T1c prostate cancer: prediction of insignificant disease using free/total prostate specific antigen levels and needle biopsy findingsJ I Epstein, D W Chan, L J Sokoll, et al.
Urology|February 1, 1995
Serum ferritin as a clinical marker for renal cell carcinoma: influence of tumor volumeA W Partin, S R Criley, M S Steiner, et al.
Journal of Andrology|August 19, 1999
Prostatic growth rate determined from MRI data: age-related longitudinal changesA M Williams, I Simon, P K Landis, et al.
Pageof 10

Showing results (71-80 of 93) with videos related to

Sort By:
Pageof 10
The Journal of Urology|July 1, 1993
The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancerA W Partin, J Yoo, H B Carter, et al.
Radiology|February 1, 1991
Nonpalpable prostate cancer: detection with MR imagingH B Carter, R F Brem, C M Tempany, et al.
Urology|April 1, 1995
Prostate-specific antigen variability in men without prostate cancer: effect of sampling interval on prostate-specific antigen velocityH B Carter, J D Pearson, Z Waclawiw, et al.
Urology|February 1, 1997
Prostate-specific antigen in men born with bladder exstrophyR I Silver, A W Partin, J I Epstein, et al.
The Journal of Urology|July 1, 1992
Correlation of prostate cancer nuclear deoxyribonucleic acid, size, shape and Gleason grade with pathological stage at radical prostatectomyJ I Epstein, G Pizov, G D Steinberg, et al.
Urology|December 1, 1996
Longitudinal analysis of serial measurements of free and total PSA among men with and without prostatic cancerJ D Pearson, A A Luderer, E J Metter, et al.
The Prostate|July 1, 1995
Longitudinal evaluation of serum androgen levels in men with and without prostate cancerH B Carter, J D Pearson, E J Metter, et al.
The Journal of Urology|November 17, 1998
Nonpalpable stage T1c prostate cancer: prediction of insignificant disease using free/total prostate specific antigen levels and needle biopsy findingsJ I Epstein, D W Chan, L J Sokoll, et al.
Urology|February 1, 1995
Serum ferritin as a clinical marker for renal cell carcinoma: influence of tumor volumeA W Partin, S R Criley, M S Steiner, et al.
Journal of Andrology|August 19, 1999
Prostatic growth rate determined from MRI data: age-related longitudinal changesA M Williams, I Simon, P K Landis, et al.
Pageof 10